Robert J. De Vaere
2013
In 2013, Robert J. De Vaere earned a total compensation of $908.9K as Executive Vice President and Chief Financial Officer at Horizon Pharma, a 4% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $187,460 |
|---|---|
| Option Awards | $89,250 |
| Salary | $374,920 |
| Stock Awards | $256,667 |
| Other | $600 |
| Total | $908,897 |
De Vaere received $374.9K in salary, accounting for 41% of the total pay in 2013.
De Vaere also received $187.5K in non-equity incentive plan, $89.3K in option awards, $256.7K in stock awards and $600 in other compensation.
Rankings
In 2013, Robert J. De Vaere's compensation ranked 7,063rd out of 12,286 executives tracked by ExecPay. In other words, De Vaere earned more than 42.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,063 out of 12,286 | 43rd |
Division Manufacturing | 2,518 out of 4,612 | 45th |
Major group Chemicals And Allied Products | 774 out of 1,462 | 47th |
Industry group Drugs | 575 out of 1,156 | 50th |
Industry Pharmaceutical Preparations | 460 out of 890 | 48th |
Source: SEC filing on June 2, 2014.
De Vaere's colleagues
We found four more compensation records of executives who worked with Robert J. De Vaere at Horizon Pharma in 2013.
2013
Timothy Walbert
Horizon Pharma
Chief Executive Officer
2013
Todd Smith
Horizon Pharma
Executive Vice President and Chief Commercial Officer
2013
Jeffrey Sherman
Horizon Pharma
Chief Medical Officer
2013
Michael Adatto
Horizon Pharma